HONG KONGSHANGHAI, Dec 14 Reuters Global investors, already caught off guard by China39;s viruspolicy Uturn, now find themselves flying blind into a chaotic postpandemic transition, lacking proper data to track rising infections and potential threats to the economy in the months ahead.

Authorities in China, where official data often confounds investors or is questioned for its reliability, have halted mass testing for COVID19 and narrowed their reporting of infections, making information even harder to come by.

Investors have been left scouring online search data or other alternatives and are tweaking their tracking models, struggling for a clear view of surging COVID infections and a potential healthcare crisis as the world39;s secondlargest economy reopens.

While confidence remains unshaken that China will emerge with stronger growth in the latter part of next year, the nearterm surge in cases poses new challenges to an economy that investors have long found difficult to read.

It39;s chaos now, said Joanna Shen, emerging markets and Asia Pacific equities investment specialist at J.P. Morgan Asset Management.

Let39;s give one month to see how things will be. Everything is so fast.

J.P.Morgan Asset Management maintains a neutral weight on China, preferring a waitandsee stance for the short term after authorities last week rolled back draconian antiCOVID policies that were strangling the economy.

Markets have also stalled this week, after hints of imminent easing…